Perspectum products, services and brand assets – logos, icons, designs, software, screen displays, trade dress and all other brand features and elements, whether registered or unregistered – are protected by international intellectual property rights and unfair competition laws.
We are the owner and licensee of international granted patents and patent applications including:
- PCT/US2007/009546,
- PCT/US2008/080426,
- PCT/US2009/040185,
- PCT/US2012/032905,
- PCT/GB2012/053118,
- PCT/GB2012/053116,
- PCT/GB2014/050815,
- PCT/EP2017/057302,
- PCT/GB2017/053344,
- PCT/EP2018/051321,
- PCT/EP2018/077957,
- PCT/EP2019/073545,
- PCT/EP2022/053393,
- PCT/EP2023/058670,
- PCT/EP2023/071834,
- PCT/IB2024/057045,
- PCT/IB2024/052937,
- PCT/IB2024/054793,
- PCT/IB2024/061028,
- PCT/IB2024/062190,
- PCT/IB2024/060990,
- PCT/IB2025/0530307,
- PCT/IB2025/053097,
- USD989,803,
- USD989,804,
- UK6413500,
- GB2415454,
- GB2414063,
- GB2417553,
- GB2501719,
- GB2502059,
- GB2503222,
- GB2508042,
- GB2601120.5,
- GB2600926.6 and all related national and regional patents and applications.
- Perspectum®,
- Perspectum Diagnostics®,
- LiverMultiScan®,
- cT1®,
- Atlas®,
- Hepatica®,
- CoverScan®,
- MRCP+®,
- Vitruvian® graphical marks ((SG) 40201903834S, (AU) 1991032, (NZ) 1114272, UK00003391362, UK00912681921, (EU) 012681921, (EU) 012679411, (US) 4691052, (US) 4691053.
- Our unregistered marks include ‘A new way to see precision health’™.
Our intellectual property portfolio is constantly growing. We assert and actively enforce our intellectual property rights to the fullest extent of the law. The absence of an intellectual property right from this list pending update does not constitute a waiver of any of our intellectual property rights.
Please contact our Intellectual Property Manager for further information ( ip@perspectum.com ).